PerpEquities

Planet Labs PBC (PL) financials

NYSE · Industrials · Aerospace & Defense · 973 employees · CEO William Spencer Marshall

Price
$10.72
Market cap
$3.58B
Enterprise value
$3.62B Data as of 2026-11-21
Last report
Q2 '27 filed 2026-09-03
Next report
2026-12-10 EPS est. -$0.03
Revenue (TTM)$378M+44.1% vs a year agoLast 4 quarters; bars = each quarter
Operating margin (TTM)-27.2%+4.4 pp vs a year agoOperating income -$103M
Net income (TTM)-$360M-297.8% vs a year agoAfter tax, incl. non-operating gains
Free cash flow (TTM)$23.4M-27.6% vs a year agoCapex $94.2M
Diluted EPS (TTM)-$1.10-260.8% vs a year agoSum of the last 4 quarters
Net cash$417M+60.3% vs a year agoCash + short-term investments - debt

Valuation & key figures

Market cap
$3.58B
Updated 1h ago
Revenue
$378M
Trailing 12 months
Revenue growth
+42%
FY2027 consensus
Profit margin
-95.1%
Net income / revenue, TTM
P/E
No P/E
Loss in the last twelve months
P/S
9.5×
Price / sales, TTM
EV / EBITDA
-11.8×
TTM
Free cash flow
$23.4M
Trailing 12 months
Net income
-$360M
Trailing 12 months
Revenue estimate
$438M
FY2027 consensus
Earnings
2026-12-10
Revenue est. $104M · Updated 1h ago
Dividend
–
No dividend

Key takeaways

Computed from the reported numbers - every statement carries the figure it rests on.

  • Last report (2026-09-03): revenue beat by 11.0%, EPS beat by 205.1%Revenue $116M vs $105M expected (+11.0%); EPS $0.02 vs -$0.02 (+205.1%).
  • Revenue growth accelerating: 58.1% year on yearQ2 '27 revenue $116M, against an average of 34.0% over the four quarters before.
  • Operating margin -27.2% (TTM), +4.4 pp on a year agoOperating income grew -24.2% while revenue grew 44.1%.
  • Capex 24.9% of revenue (a year ago 19.3%)$94.2M invested in the last 4 quarters (+86.4% on a year earlier). Free cash flow $23.4M.
  • Diluted share count up 18.2% in a year360M diluted shares in Q2 '27, 304M a year earlier.
  • Net cash $417MCash + short-term investments $865M, debt incl. leases $448M; a year ago net cash $260M.

Last quarter: Q2 '27

Quarter ended 2026-07-31. Compared with the same quarter a year earlier and with the analyst consensus before the report.

Quarter vs a year ago

Q2 '27Year agoChange
Revenue$116M$73.4M+58.1%
Gross margin56.6%57.6%-1.0 pp
Operating income-$13.5M-$18M+24.8%
Operating margin-11.6%-24.5%+12.8 pp
Net income-$9.35M-$22.6M+58.6%
Diluted EPS-$0.03-$0.07+59.6%
Operating cash flow$52.9M$67.8M-21.9%
Capex$27.3M$18.4M+48.3%
Free cash flow$25.6M$49.3M-48.1%
R&D$35.2M$24.2M+45.5%
Stock-based compensation$17.1M$13.5M+26.8%

Reported vs consensus

2026-09-03
ActualConsensusvs consensus
Revenue$116M$105M+11.0%
EPS (as estimated)$0.02-$0.02+205.1%

From the report of 2026-09-03 for Q2 '27: revenue and the EPS analysts estimate (often adjusted), so it can differ from the EPS of the statements above.

EPS vs consensus

last 8 reports

Revenue

Where the money comes from - by business line and by region, quarter by quarter.

Revenue, operating income and growth

quarterly

Revenue by business line

stacked, quarterly
SegmentQ2 '26y/yShare of listedTTMTTM y/y12 quarters
Reportable Segment$73.4M–100.0%––

Revenue by region

share of the listed regions
SegmentQ2 '27y/yShare of listedTTMTTM y/y12 quarters
EMEA$55.2M+135.2%47.6%––
North America$39M+25.5%33.6%––
Asia Pacific And Japan$19.1M+18.2%16.5%––
Latin America$2.74M+2.5%2.4%––

Margins & cost structure

How much of each unit of revenue is left at each level - and where the costs go.

Margins

quarterly

Costs as % of revenue

quarterly

Cash flow & capital allocation

Cash generated, what it is spent on, and what reaches shareholders.

Operating cash flow, capex, free cash flow

quarterly

Uses of cash vs operating cash flow

fiscal years

Last 4 quarters

cash flow statement
Operating cash flow
$118M
Capex
-$94.2M
Buybacks
$86.1M
Dividends
$0
Acquisitions
-$1.35M
Net debt issued
$406M
Stock-based compensation
$62.5M
Free cash flow
$23.4M
Returned to shareholders / FCF
-367.3%

Share count and EPS

quarterly, diluted

Balance sheet

Liquidity, investments and debt at each quarter end.

Cash, investments and debt

quarter ends

Valuation & returns

Today's multiples against the company's own last five fiscal years; analyst targets and ratings.

Multiples and returns

TTM vs 5 fiscal years
Now5y averageWhere today sits in the 5-year range
P/E (TTM)–––
EV / EBITDA-11.8×––
EV / Sales9.6×9.9×2.6× – 25.7×
Price / FCF153.0×133.3× 1 of 5 years133.3× – 133.3×
Price / Book6.7×10.2×1.2× – 40.8×
FCF yield0.7%-5.5%-14.7% – 0.8%
Return on invested capital-9.5%-22.6%-29.6% – -13.9%
Return on equity-93.1%-47.1%-131.0% – -21.2%

Analysts

Consensus target $28.63 (+171.9%)
range $17.00 – $40.00 · rating Buy

Strong buy0
Buy13
Hold10
Sell0
Strong sell0

Outlook

Analyst consensus for the coming fiscal years and what it implies at today's price.

Consensus estimates

Fiscal yearRevenueGrowthEPSGrowthP/E at today's priceAnalysts (EPS)
FY2027$438M+42.2%-$0.05+94.1%–5
FY2028$571M+30.6%$0.01+129.9%766.3×6
FY2029$736M+28.8%$0.14+902.4%76.5×3
FY2030$843M+14.6%$0.25+78.3%42.9×1

Financial statements

Every line of the income statement, balance sheet and cash flow statement - 12 quarters and 10 fiscal years, as values, as % of revenue or as growth.

Every reported line

All 249 figures Planet Labs PBC tagged in its recent 10-Q / 10-K filings, with the official SEC label and definition - including the notes (leases, taxes, buybacks, employees, ...).

Line (SEC label)Latest quarterYear agoy/yLatest FYPrior FYy/y
Accounts Payable, Current$10.4M$11.1M-6.3%$10.6M$2.6M+307.5%
Accounts Receivable, after Allowance for Credit Loss, Current$59.9M$51.6M+16.0%$83.5M$55.8M+49.6%
Accounts Receivable, Allowance for Credit Loss, Current$0$396K-100.0%$3$807-99.6%
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment$234M$258M-9.5%$238M$247M-3.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax$3.37M$3.85M-12.5%$6.36M-$1.1M+679.9%
Additional Paid in Capital$2.16B$1.67B+29.3%$1.63B$1.65B-0.8%
Amortization of Intangible Assets$1.8M$1.5M+20.0%$5.9M$5.8M+1.7%
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount-3.83M-5.37M+28.7%102M96.1M+5.9%
APIC, Share-based Payment Arrangement, Increase for Cost Recognition$18M$14.1M+27.3%$57.6M$50.8M+13.3%
Asset Impairment Charges–––$0$0–
AssetAcquisitionContingentConsiderationLiability$02026-01-31$4.68M-100.0%$0$4.68M-100.0%
Assets$1.43B$696M+105.5%$1.15B$634M+80.8%
Assets, Current$999M$355M+181.0%$775M$302M+156.6%
Business Combination, Consideration Transferred, Liabilities Incurred–––$0$0–
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability$0$717K-100.0%$465K$3.44M-86.5%
Business Combination, Contingent Consideration, Liability, Current$1.21M2025-10-31$4.41M-72.6%$4.7M2025-01-31$7.01M-32.9%
Business Combination, Contingent Consideration, Liability, Noncurrent$02026-01-31$2.88M-100.0%$0$2.88M-100.0%
Capital Expenditures Incurred but Not yet Paid–––$5.02M$718K+599.0%
Capitalized Computer Software, Accumulated Amortization$38.6M$34M+13.5%$36M$32.6M+10.6%
Capitalized Computer Software, Amortization$1.3M$700K+85.7%$3.4M$2.5M+36.0%
Capitalized Computer Software, Gross$60.6M$54.6M+11.1%$57.5M$51.5M+11.6%
Capitalized Computer Software, Net$22.1M$20.6M+7.2%$21.5M$19M+13.2%
Capitalized Contract Cost, Amortization$500K$500K0.0%$2.1M$2.9M-27.6%
Capitalized Contract Cost, Net$3.9M$3.63M+7.4%$4.32M$3.7M+16.7%
Capitalized Contract Cost, Net, Current$2.2M$1.65M+33.6%$1.91M$1.98M-3.5%
Capitalized Contract Cost, Net, Noncurrent$1.7M$1.99M-14.4%$2.41M$1.72M+40.0%
Cash and Cash Equivalents, at Carrying Value$415M$181M+129.2%$229M$118M+94.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents$424M$193M+119.6%$236M$130M+81.2%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect$48M$47.3M+1.5%$106M$27.8M+279.8%
Class of Warrant or Right, Exercise Price of Warrants or Rights$9.38––$9.38$9.380.0%
Class of Warrant or Right, Outstanding1.07M––1.07M1.07M0.0%
Common Stock, Par or Stated Value Per Share$0.00$0.000.0%$0.00$0.000.0%
Common Stock, Value, Issued$36K$28K+28.6%$34K$28K+21.4%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent-$10.9M-$22.4M+51.4%-$239M-$126M-90.2%
Concentration Risk, Credit Risk, Financial Instrument, Maximum Exposure$133M$45.5M+192.7%$638M$220M+190.2%
Contract with Customer, Liability, Current$281M$148M+90.0%$221M$82.3M+168.1%
Contract with Customer, Liability, Noncurrent$17.4M$25M-30.6%$27.5M$11.2M+146.1%
Contract with Customer, Liability, Revenue Recognized$62.8M$26M+141.5%$79.4M$68.8M+15.4%
Convertible Notes Payable$448M––$447M$0–
Cost of Goods and Services Sold$50.4M$31.1M+62.0%$135M$105M+29.3%
Current Federal Tax Expense (Benefit)–––$37K$0–
Current Foreign Tax Expense (Benefit)–––$4.52M$2.31M+95.8%
Current Income Tax Expense (Benefit)–––$4.6M$2.36M+94.7%
Current State and Local Tax Expense (Benefit)–––$43K$54K-20.4%
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax$33K$73K-54.8%$434K$215K+101.9%
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax$778K$48K+1,520.8%$19K$74K-74.3%
Debt Securities, Available-for-sale, Amortized Cost, Current$451M$90.4M+398.8%$410M$104M+294.9%
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One$260M$31M+739.7%$270M$61M+343.4%
Debt Securities, Available-for-sale, Current$450M$90.5M+397.8%$411M$104M+294.8%
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One$260M$31M+738.0%$271M$61.2M+342.3%
Deferred Federal Income Tax Expense (Benefit)–––$197K-$642K+130.7%
Deferred Foreign Income Tax Expense (Benefit)–––$3K$25K-88.0%
Deferred Income Tax Expense (Benefit)–––$56K$98K-42.9%
Deferred State and Local Income Tax Expense (Benefit)–––-$144K$715K-120.1%
Deferred Tax Assets, Gross$358M2026-01-31$297M+20.4%$358M$297M+20.4%
Deferred Tax Assets, in Process Research and Development$20.8M2026-01-31$67M-69.0%$20.8M$67M-69.0%
Deferred Tax Assets, Net of Valuation Allowance$12.2M2026-01-31$12.4M-1.2%$12.2M$12.4M-1.2%
Deferred Tax Assets, Operating Loss Carryforwards$241M2026-01-31$143M+68.6%$241M$143M+68.6%
Deferred Tax Assets, Other$9.09M2026-01-31$5.68M+60.0%$9.09M$5.68M+60.0%
Deferred Tax Assets, Property, Plant and Equipment$16.3M2026-01-31$19.2M-15.4%$16.3M$19.2M-15.4%

Source: SEC companyfacts (XBRL of every 10-Q / 10-K). Cash-flow quarters are derived from the year-to-date figures the 10-Q tags. Segment breakdowns are tagged with dimensions and are shown in the segment section instead.

Sources

Statements, segment revenue, metrics and estimates are standardised from the company's filings. Segment profits and every reported line: SEC EDGAR (XBRL). Filings read: 10-Q 2026-07-31, 10-Q 2026-04-30, 10-K 2026-01-31, 10-Q 2025-10-31, 10-Q 2025-07-31, 10-Q 2025-04-30, 10-K 2025-01-31, 10-Q 2024-10-31, 10-Q 2024-07-31

Data as of 2026-11-21